338 related articles for article (PubMed ID: 16647119)
1. Development and biological properties of a new live attenuated mumps vaccine.
Saika S; Kidokoro M; Kubonoya H; Ito K; Ohkawa T; Aoki A; Nagata N; Suzuki K
Comp Immunol Microbiol Infect Dis; 2006; 29(2-3):89-99. PubMed ID: 16647119
[TBL] [Abstract][Full Text] [Related]
2. Rubini, a new live attenuated mumps vaccine virus strain for human diploid cells.
Glück R; Hoskins JM; Wegmann A; Just M; Germanier R
Dev Biol Stand; 1986; 65():29-35. PubMed ID: 3556774
[TBL] [Abstract][Full Text] [Related]
3. Neurovirulence of mumps virus: intraspinal inoculation test in marmosets.
Saika S; Kidokoro M; Aoki A; Ohkawa T
Biologicals; 2004 Sep; 32(3):147-52. PubMed ID: 15536045
[TBL] [Abstract][Full Text] [Related]
4. Identification and development of a promising novel mumps vaccine candidate strain.
Liang Y; Ma S; Liu L; Zhao H; Wang L; Jiang L; Xie Z; Dong C; Li Q
Microbes Infect; 2010 Dec; 12(14-15):1178-87. PubMed ID: 20800105
[TBL] [Abstract][Full Text] [Related]
5. The mumps virus neurovirulence safety test in Rhesus monkeys: a comparison of mumps virus strains.
Rubin SA; Snoy PJ; Wright KE; Brown EG; Reeve P; Beeler JA; Carbone KM
J Infect Dis; 1999 Aug; 180(2):521-5. PubMed ID: 10395874
[TBL] [Abstract][Full Text] [Related]
6. Simple differentiation method of mumps Hoshino vaccine strain from wild strains by reverse transcription loop-mediated isothermal amplification (RT-LAMP).
Yoshida N; Fujino M; Ota Y; Notomi T; Nakayama T
Vaccine; 2007 Jan; 25(7):1281-6. PubMed ID: 17097200
[TBL] [Abstract][Full Text] [Related]
7. Presence of lysine at aa 335 of the hemagglutinin-neuraminidase protein of mumps virus vaccine strain Urabe AM9 is not a requirement for neurovirulence.
Sauder CJ; Zhang CX; Link MA; Duprex WP; Carbone KM; Rubin SA
Vaccine; 2009 Sep; 27(42):5822-9. PubMed ID: 19660591
[TBL] [Abstract][Full Text] [Related]
8. Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak.
Rubin SA; Qi L; Audet SA; Sullivan B; Carbone KM; Bellini WJ; Rota PA; Sirota L; Beeler J
J Infect Dis; 2008 Aug; 198(4):508-15. PubMed ID: 18558869
[TBL] [Abstract][Full Text] [Related]
9. Studies on live attenuated mumps vaccine. II. Follow-up study on the efficacy of Biken Vaccine.
Isomura S; Ozaki T; Morishima T; Nagayoshi S; An S
Biken J; 1976 Sep; 19(3):115-8. PubMed ID: 1016214
[TBL] [Abstract][Full Text] [Related]
10. Pathogenicity of mumps virus in the marmoset.
Saika S; Kidokoro M; Ohkawa T; Aoki A; Suzuki K
J Med Virol; 2002 Jan; 66(1):115-22. PubMed ID: 11748667
[TBL] [Abstract][Full Text] [Related]
11. Investigation of mumps vaccine failures in Minsk, Belarus, 2001-2003.
Atrasheuskaya AV; Blatun EM; Kulak MV; Atrasheuskaya A; Karpov IA; Rubin S; Ignatyev GM
Vaccine; 2007 Jun; 25(24):4651-8. PubMed ID: 17498853
[TBL] [Abstract][Full Text] [Related]
12. Mumps vaccine failure investigation in Novosibirsk, Russia, 2002-2004.
Atrasheuskaya AV; Kulak MV; Rubin S; Ignatyev GM
Clin Microbiol Infect; 2007 Jul; 13(7):670-6. PubMed ID: 17484765
[TBL] [Abstract][Full Text] [Related]
13. Detection of mumps virus genome directly from clinical samples and a simple method for genetic differentiation of the Hoshino vaccine strain from wild strains of mumps virus.
Kashiwagi Y; Kawashima H; Takekuma K; Hoshika A; Mori T; Nakayama T
J Med Virol; 1997 Jun; 52(2):195-9. PubMed ID: 9179768
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo growth alter the population dynamic and properties of a Jeryl Lynn mumps vaccine.
Connaughton SM; Wheeler JX; Vitková E; Minor P; Schepelmann S
Vaccine; 2015 Aug; 33(36):4586-93. PubMed ID: 26187256
[TBL] [Abstract][Full Text] [Related]
15. Generation of a recombinant Oka varicella vaccine expressing mumps virus hemagglutinin-neuraminidase protein as a polyvalent live vaccine.
Somboonthum P; Yoshii H; Okamoto S; Koike M; Gomi Y; Uchiyama Y; Takahashi M; Yamanishi K; Mori Y
Vaccine; 2007 Dec; 25(52):8741-55. PubMed ID: 18053621
[TBL] [Abstract][Full Text] [Related]
16. Intranasal immunization with mumps virus DNA vaccine delivered by influenza virosomes elicits mucosal and systemic immunity.
Cusi MG; Zurbriggen R; Valassina M; Bianchi S; Durrer P; Valensin PE; Donati M; Glück R
Virology; 2000 Nov; 277(1):111-8. PubMed ID: 11062041
[TBL] [Abstract][Full Text] [Related]
17. Comparative study on the neurovirulence of different vaccine strains of parotitis virus in monkeys.
Rozina EE; Hilgenfeldt M
Acta Virol; 1985 May; 29(3):225-30. PubMed ID: 2864823
[TBL] [Abstract][Full Text] [Related]
18. Persistence of immunity four years following Jeryl Lynn strain live mumps virus vaccine.
Weibel RE; Buynak EB; Stokes J; Hilleman MR
Pediatrics; 1970 May; 45(5):821-6. PubMed ID: 5444402
[No Abstract] [Full Text] [Related]
19. Changes in mumps virus neurovirulence phenotype associated with quasispecies heterogeneity.
Sauder CJ; Vandenburgh KM; Iskow RC; Malik T; Carbone KM; Rubin SA
Virology; 2006 Jun; 350(1):48-57. PubMed ID: 16494912
[TBL] [Abstract][Full Text] [Related]
20. Clinical trial of new attenuated mumps virus vaccine (Jeryl Lynn strain): preliminary report.
Pagano JS; Levine RH; Sugg WC; Finger JA
Prog Immunobiol Stand; 1967; 3():196-202. PubMed ID: 4908595
[No Abstract] [Full Text] [Related]
[Next] [New Search]
